前 OpenAI 科學主管 Kevin Weil 推出 Warp Sciences,獲 $215M 融資發展藥物化學服務
Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
前 OpenAI 科學主管 Kevin Weil 創辦的 Warp Sciences 正式成立,並獲得 $215M 融資,主攻藥物發現化學服務。公司在美國建立化學合約研究機構,首項服務是先導化合物優化的類似物合成,為客戶製作可供比較的分子變體。實驗數據將用於訓練 AI 模型,實驗室亦會在化學家指導下逐步增加自動化。
Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
![]()
Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC.
Warp is building a chemistry contract research organization in the U.S. to supply biotech and pharmaceutical companies with the molecules their drug programs need. Lead optimization analog synthesis is the first service. That work produces variations on a promising molecule for the customer’s scientists to compare as they narrow in on a drug candidate.
Data from those physical experiments will train Warp’s artificial intelligence models, with experienced chemists guiding the work as the lab takes on more automation. Robots will learn lab tasks from chemists wearing cameras and sensor gloves, TechCrunch reported.
Weil said in the launch announcement that the physical sciences have yet to get the lift from AI that has “dramatically accelerated software engineering and mathematics.” Chemistry and biology advance when someone makes a compound and tests it, according to Weil, so AI models for science need “real-world data at scale.”
Sol Reisberg, Warp’s co-founder and chief scientific officer, previously led medicinal chemistry work at Terremoto Biosciences Inc. Overseas chemistry partners he worked with in the past left him worried about protecting the intellectual property behind his programs. Hiring a boutique U.S. contract research firm instead means paying what he called a “price premium.” Warp aims to match the caliber of those overseas partners from labs in the U.S., at prices that leave the markup out.
A lot of that overseas work ends up in China. Contracts with Chinese companies for preclinical and clinical services were in place at 74% of the 124 biotech companies the Biotechnology Innovation Organization surveyed in 2024, according to Reuters. The BIOSECURE Act now restricts federal contracts and grants involving designated “biotechnology companies of concern.” President Donald Trump signed it into law in December.
As a contractor, Warp makes only the molecules its customers choose. “We’re not developing drugs of our own,” said co-founder and Chief Operating Officer DJ Patil.
Patil was a founding executive at Devoted Health Inc. after serving as the White House’s first chief data scientist. The fourth co-founder, Chief Technology Officer Mano Paluri, was part of the team that started Meta Platforms Inc.’s AI research group years before he became a vice president at Meta Superintelligence Labs.
Lightspeed Venture Partners LP led the funding round. The 18 other participating firms include Institutional Venture Partners LP, Lux Capital Management and Menlo Ventures LP. Coinbase Global Inc. Chief Executive Brian Armstrong and OpenAI Chief Financial Officer Sarah Friar invested as individuals, as did 11 other angel investors.
Image: SiliconANGLE/GPT Image 2.5
A message from John Furrier, co-founder of SiliconANGLE:
Support our mission to keep content open and free by engaging with theCUBE community. Join theCUBE’s Alumni Trust Network, where technology leaders connect, share intelligence and create opportunities.
- 15M+ viewers of theCUBE videos, powering conversations across AI, cloud, cybersecurity and more
- 11.4k+ theCUBE alumni — Connect with more than 11,400 tech and business leaders shaping the future through a unique trusted-based network
SiliconANGLE Media is a recognized leader in digital media innovation, uniting breakthrough technology, strategic insights and real-time audience engagement. As the parent company of SiliconANGLE, theCUBE Network, theCUBE Research, CUBE365, theCUBE AI and theCUBE SuperStudios — with flagship locations in Silicon Valley and the New York Stock Exchange — SiliconANGLE Media operates at the intersection of media, technology and AI.
Founded by tech visionaries John Furrier and Dave Vellante, SiliconANGLE Media has built a dynamic ecosystem of industry-leading digital media brands that reach 15+ million elite tech professionals. Our new proprietary theCUBE AI Video Cloud is breaking ground in audience interaction, leveraging theCUBEai.com neural network to help technology companies make data-driven decisions and stay at the forefront of industry conversations.
來源:SiliconANGLE · siliconangle.com